Understanding muscle loss in heart failure patients
Official title: Socioeconomic Factors and Mechanisms of Sarcopenia and Muscle Strength in Chronic Heart Failure Patients
Run by Aarhus University Hospital · NCT05063955 · Data updated 2026-11-12
This study looks at how factors like lifestyle and nutrition affect muscle loss in people with heart failure compared to healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Aarhus University Hospital Academic / other |
| Locations | 1 site (Aarhus N) |
| Status | Recruiting |
| Started | December 2, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2033 |
| Registry record updated | December 26, 2023 |
| Trial ID | NCT05063955 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with heart failure of any ejection fraction (NYHA I-IV) who can provide informed consent.
✕Probably not a fit
Patients with severe musculoskeletal or neurological disabilities, severe lung disease, or those on anticoagulant treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore how socioeconomic factors, daily physical activity, nutrition, and lifestyle contribute to muscle mass and function loss in patients with heart failure. It will involve 200 heart failure patients and 50 healthy controls matched by age and sex. Researchers will collect baseline data on body composition, physical capacity, nutritional status, and quality of life, along with skeletal muscle biopsies and blood samples for analysis. Follow-up visits will occur at 12 and 36 months to assess changes over time.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of muscle loss in heart failure patients, potentially enhancing their quality of life.
How similar studies have gone: While the specific interactions being studied may be novel, similar studies have shown that understanding the relationship between muscle loss and heart failure can lead to better patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Ability to provide valid informed consent. 2. Heart failure with preserved, mid-range or reduced ejection fraction (NYHA I-IV) according to European Society of Cardiology guidelines. Exclusion Criteria: 1. Cancer requiring treatment (e.g. prostate cancer on watchful waiting does not exclude patients). 2. Severe musculoskeletal or neurological disability. 3. Severe lung disease with a forced expiratory volume 1 \< 40% of predicted. Treatment with anticoagulants (warfarin, apixaban, edoxaban, dabigatran and rivaroxaban) is an exclusion criterion for muscle biopsy. Patients with anticoagulant treatment will be invited to participate in the study without muscle biopsy. 4. Other comorbidities that prevent the patient from participating in the study examinations as judged by the investigator.
Where it's running
-
Aarhus University Hospital
Aarhus N, Denmark Recruiting
Study contacts
- Study coordinator: Henrik Wiggers, Prof.
- Email: henrikwiggers@dadlnet.dk
- Phone: +45 2275 3202
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Spatial multi-omics and AI-based early warning for pancreatic cancer cachexia
This study tests whether spatial multi-omics data can reveal how the tumor and body metabolism interact in pancreatic cancer cachexia and whether a multimodal AI model can predict cachexia early in adults with pancreatic ductal adenocarcinoma.
-
Sarcopenia in older adults with acute heart failure: using muscle ultrasound and biomarkers to predict outcomes
This study tests whether measuring muscle mass with ultrasound, along with muscle strength and biomarkers, can help predict outcomes for adults 80 and older hospitalized for acute heart failure with preserved ejection fraction.
-
Pathogenesis and Reversal Strategies for Cancer Cachexia Using Multi-Omics
This study uses multiple omics methods and nutritional interventions to try to find causes and reversal strategies for cachexia in adults with gastrointestinal cancers.
-
High-protein, plant-dominant diet for people with liver cirrhosis
This 6-month test compares a high-protein, mostly plant-based diet to a usual low-fat animal-protein diet in adults with decompensated cirrhosis who are awaiting kidney transplant to see which better preserves nutrition and muscle.
-
Examining how muscle loss affects disease progression
This study is trying to see how muscle loss affects the health and recovery of patients with liver cirrhosis, cancer, and those on breathing machines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.